153 related articles for article (PubMed ID: 31505209)
21. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
Muñoz-Elías EJ; McKinney JD
Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
[TBL] [Abstract][Full Text] [Related]
22. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
[TBL] [Abstract][Full Text] [Related]
23. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C
Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230
[TBL] [Abstract][Full Text] [Related]
24. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
26. ¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.
Beste DJ; Bonde B; Hawkins N; Ward JL; Beale MH; Noack S; Nöh K; Kruger NJ; Ratcliffe RG; McFadden J
PLoS Pathog; 2011 Jul; 7(7):e1002091. PubMed ID: 21814509
[TBL] [Abstract][Full Text] [Related]
27. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
28. Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2.
Bhusal RP; Jiao W; Kwai BXC; Reynisson J; Collins AJ; Sperry J; Bashiri G; Leung IKH
Nat Commun; 2019 Oct; 10(1):4639. PubMed ID: 31604954
[TBL] [Abstract][Full Text] [Related]
29. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
Shukla R; Shukla H; Tripathi T
Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
[TBL] [Abstract][Full Text] [Related]
30. Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis.
Upton AM; McKinney JD
Microbiology (Reading); 2007 Dec; 153(Pt 12):3973-3982. PubMed ID: 18048912
[TBL] [Abstract][Full Text] [Related]
31. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
32. Targeting isocitrate lyase for the treatment of latent tuberculosis.
Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
[TBL] [Abstract][Full Text] [Related]
33. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof].
Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772
[TBL] [Abstract][Full Text] [Related]
34. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
[TBL] [Abstract][Full Text] [Related]
35. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence.
Muñoz-Elías EJ; Upton AM; Cherian J; McKinney JD
Mol Microbiol; 2006 Jun; 60(5):1109-22. PubMed ID: 16689789
[TBL] [Abstract][Full Text] [Related]
36. Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening.
Ji L; Long Q; Yang D; Xie J
Int J Biol Sci; 2011 Apr; 7(3):376-82. PubMed ID: 21494431
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the
Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
[TBL] [Abstract][Full Text] [Related]
39. Covalent Inactivation of
Pham TV; Mellott DM; Moghadamchargari Z; Chen K; Krieger I; Laganowsky A; Sacchettini JC; Meek TD
ACS Chem Biol; 2021 Mar; 16(3):463-470. PubMed ID: 33688722
[TBL] [Abstract][Full Text] [Related]
40. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility.
Shukla H; Shukla R; Sonkar A; Pandey T; Tripathi T
Sci Rep; 2017 Apr; 7(1):1058. PubMed ID: 28432345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
